Akkarco LLC Recalls Ashfiat Alharamain Energy Support Over Undeclared Tadalafil

Akkarco LLC of Lorton, Virginia, is voluntarily recalling its Ashfiat Alharamain Energy Support product after testing revealed the presence of undeclared tadalafil, a prescription drug used to treat male erectile dysfunction. Tadalafil belongs to a class of medications known as phosphodiesterase (PDE5) inhibitors and is approved by the U.S. Food and Drug Administration only for use under medical supervision. Products containing tadalafil cannot be legally marketed as dietary supplements, and this product is considered an unapproved new drug with unverified safety and effectiveness.

Use of unauthorized products containing tadalafil may pose serious health risks, especially for individuals with heart conditions or those taking certain medications. Potential side effects include cardiovascular issues, blood pressure fluctuations, dizziness, and headaches.

The product was distributed nationwide, including online marketplaces. No adverse events have been reported. Consumers should stop using it immediately and contact FDA MedWatch to report any side effects.

16-02-2026